Hjem › Autoimmune sykdommer › Massachusetts
Kliniske studier for Autoimmune sykdommer i Massachusetts
16 studier for Autoimmune sykdommer søker deltakere på steder i Massachusetts.
Byer i Massachusetts
Offisiell studietekst (engelsk)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Tufts Medical Center, Boston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07621809Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Massachusetts General Hospital, Boston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06722235RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Boston Children's Hospital - Accepting Young Adults and Juvenile Patients, Boston
RekruttererFase 2/3
Alder 6 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06154252A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Massachusetts General Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06948318The Mycophenolate Pregnancy Registry
- Quintiles Outcome, Cambridge
RekruttererObservasjonsstudie
Alle aldre · Kvinner · Oppdatert 8. sep. 2026 · NCT01733082RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
- og 2 flere
RekruttererFase 1/2
Alder 18 til 65 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06121297Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder
- MGH Lurie Center for Autism, Lexington
RekruttererTidlig fase 1
Alder 18 til 50 · Menn · Oppdatert 19. aug. 2026 · NCT06934915RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Beth Israel Deaconess Medical Center, Boston
- University of Massachusetts Chan Medical School, Worcester
RekruttererFase 1/2
Alder 18 til 70 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT06359041A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Boston Children's Cancer Center, Boston
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06056297Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1049, Foxborough
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 30. jul. 2026 · NCT07039916A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Brigham And Womens Hospital, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT07115745A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Tufts Medical Center, Boston
- Beth Israel Deaconess, Boston
- Dana Farber Cancer Institute, Boston
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Tufts University, Boston
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 30. jun. 2026 · NCT06201416A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Brigham and Women's Hospital, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. mai 2026 · NCT04422912Testimonials and Navigation in Rheumatology
- Brigham Women's Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT06469788Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.